Cervical Cancer Clinical Trials in Georgia

Cancer Type = Cervical Cancer

Cancer Type = Cervical Cancer

There are currently 13 active Cervical Cancer clinical trials in Georgia.
1.
A Phase 1 Multiple-Dose Study to Evaluate the Safety and Tolerability of XmAb®22841 Monotherapy and in Combination With Pembrolizumab in Subjects With Selected Advanced Solid Tumors (DUET-4)
Cancer Type
Breast Cancer, Cervical Cancer, Colon/Rectal Cancer, Eye Cancer, Head and Neck Cancer, Kidney Cancer, Lung Cancer, Melanoma, Pancreatic Cancer, Prostate Cancer , Skin Cancer (Non-Melanoma), Stomach/ Gastric Cancer, Unknown Primary
NCI ID
NCT03849469
Protocol IDs
XmAb22841-01
NCI-2019-02498
DUET-4
3.
A Phase I / 2a Dose Escalation and Cohort Expansion Study of the Safety, Tolerability, and Efficacy of Anti-LAG-3 Monoclonal Antibody (BMS-986016) Administered Alone and in Combination With Anti-PD-1 Monoclonal Antibody (Nivolumab, BMS-936558) in Advanced Solid Tumors
Cancer Type
Bladder Cancer, Cervical Cancer, Kidney Cancer, Lung Cancer, Melanoma, Ovarian Cancer, Skin Cancer (Non-Melanoma), Stomach/ Gastric Cancer, Unknown Primary
NCI ID
NCT01968109
Protocol IDs
CA224-020
NCI-2014-00315
2014-002605-38
5.
NCORP Trial
A Stepped-Care Telehealth Approach to Treat Distress in Rural Cancer Survivors
Cancer Type
Breast Cancer, Cervical Cancer, Lymphoma, Prostate Cancer
NCI ID
NCT03190291
Protocol IDs
WF-30917CD
WF-30917CD
WF-30917CD
NCI-2017-01840
Treatment Sites (1)
8.
MRI- and PET-Predictive-Assay of Treatment Outcome in Cancer of the Cervix
Cancer Type
Cervical Cancer
NCI ID
NCT01992861
Protocol IDs
8118
NCI-2013-01935
P30CA015704
R01CA155454
9.
Phase 1 / 2 Dose-Escalation and Expansion Study of FLX475 Alone and in Combination With Pembrolizumab in Advanced Cancer
Cancer Type
Breast Cancer, Cervical Cancer, Head and Neck Cancer, Lung Cancer, Lymphoma, Ovarian Cancer, Skin Cancer (Non-Melanoma), Stomach/ Gastric Cancer, Unknown Primary
NCI ID
NCT03674567
Protocol IDs
FLX475-02
NCI-2019-00102
10.
Phase 1-2 Study of the Safety, Pharmacokinetics, and Preliminary Activity of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas
Cancer Type
Cervical Cancer, Lymphoma, Skin Cancer (Non-Melanoma), Unknown Primary
NCI ID
NCT02503423
Protocol IDs
ASTX660-01
NCI-2017-01760
11.
NCORP Trial
Phase II Double Blind Dose Finding Trial of Bupropion versus Placebo for Sexual Desire in Women with Breast or Gynecologic Cancer
Cancer Type
Breast Cancer, Cervical Cancer, Gynecologic Cancers, Ovarian Cancer
NCI ID
NCT03180294
Protocol IDs
NRG-CC004
NRG-CC004
NRG-CC004
NCI-2017-00344
Treatment Sites (1)
Georgia CORE

 

Hearts and Minds Dedicated to Improving Cancer Care

Georgia CORE is a public-private partnership that creates collaboration among the state’s cancer organizations and institutions to connect more Georgians to quality, personalized cancer care. We welcome you to this one-of-a-kind online information center for all things related to cancer and survivorship care in Georgia.